GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA
Co-development of innovative new drug for the treatment of Fabry disease as "the world's first once-monthly subcutaneous treatment"Improves efficacy compared…
